This opportunity is no longer accepting applications.
grant PAR-22-049

Integrating Biospecimen Science Approaches into Clinical Assay Development (U01 Clinical Trial Not Allowed)

This grant supports research on how to address challenges in developing and validating clinical assays due to variability in how biospecimens like tumor tissue biopsies and blood samples are handled. The research will explore how factors such as collection, processing, and storage of small biopsies, liquid biopsies, and other specimens like tissue swabs, bodily fluids, and secretions impact th…

This Funding Opportunity Announcement (FOA) will support extramural research to investigate and mitigate challenges facing clinical assay development and subsequent analytical validation due to preanalytical variability in tumor tissue biopsies, blood biospecimens utilized as liquid biopsies", o…

Funding Source

Agency: National Institutes of Health
Program: SBIR

Awards & funding

Award Ceiling: $250,000
Award Amount: $250,000

Dates

Application Window Closes: September 13, 2024
Opportunity Released: October 21, 2021
Open for Submission: October 21, 2021
Submission Deadline: September 13, 2024

Documents

Secure Grant Funding 10x Faster

Scout delivers AI-powered grant writing paired with experts that's faster, more affordable, and built to win.

Already have an account? Sign In

Trusted by 500+ Happy Customers

Get opportunities sent to your inbox

The latest grant news and insights from our experts.

Save this opportunity and explore more

Share Opportunity

Share this opportunity with others.
Anyone with this link can view the opportunity details.